TrialThe European respiratory journal2024

Clinical response and on-treatment clinical remission with tezepelumab in a broad population of patients with severe, uncontrolled asthma: results over 2 years from the NAVIGATOR and DESTINATION studies.

Michael E Wechsler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.